ANGN
Price:
$1
Market Cap:
$30.11M
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
ANGN
According to Angion Biomedica Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 22.43M. This represents a change of -302.30% compared to the average of -11085109.73 of the last 4 quarters.
The mean historical Enterprise Value of Angion Biomedica Corp. over the last ten years is 228.37M. The current 22.43M Enterprise Value has changed 882.01% with respect to the historical average. Over the past ten years (40 quarters), ANGN's Enterprise Value was at its highest in in the December 2020 quarter at 511.75M. The Enterprise Value was at its lowest in in the June 2022 quarter at -25004769.96.
Average
228.37M
Median
290.90M
Minimum
-22395965.45
Maximum
511.75M
Discovering the peaks and valleys of Angion Biomedica Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 925.45%
Maximum Annual Enterprise Value = 511.75M
Minimum Annual Increase = -100.43%
Minimum Annual Enterprise Value = -22395965.45
Year | Enterprise Value | Change |
---|---|---|
2022 | -22395965.45 | 925.45% |
2021 | -2184007.50 | -100.43% |
2020 | 511.75M | 74.76% |
2019 | 292.84M | 24.10% |
2018 | 235.98M | -18.88% |
2013 | 290.90M | -0.26% |
The current Enterprise Value of Angion Biomedica Corp. (ANGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
162.39M
5-year avg
203.20M
10-year avg
228.37M
Angion Biomedica Corp.’s Enterprise Value is greater than eFFECTOR Therapeutics, Inc. (3.64M), less than Landos Biopharma, Inc. (42.62M), greater than Apexigen, Inc. (205.32K), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), less than Oncorus, Inc. (51.18M), greater than Apollomics, Inc. (-9082481.00), less than Sigilon Therapeutics, Inc. (43.98M), less than Pyxis Oncology, Inc. (220.13M), less than Zura Bio Limited (90.25M), greater than Altamira Therapeutics Ltd. (1.17M), greater than Elevation Oncology, Inc. (2.36M), greater than ZyVersa Therapeutics, Inc. (1.84M), greater than Palisade Bio, Inc. (-7153934.00), less than Unicycive Therapeutics, Inc. (50.32M), greater than Immix Biopharma, Inc. (20.49M),
Company | Enterprise Value | Market cap |
---|---|---|
3.64M | $1.88K | |
42.62M | $71.68M | |
205.32K | $9.57M | |
-2504975.00 | $100.08K | |
51.18M | $3.14M | |
-9082481.00 | $12.39M | |
43.98M | $56.22M | |
220.13M | $225.81M | |
90.25M | $278.69M | |
1.17M | $1.96M | |
2.36M | $30.89M | |
1.84M | $1.96M | |
-7153934.00 | $3.70M | |
50.32M | $45.28M | |
20.49M | $43.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Angion Biomedica Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Angion Biomedica Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Angion Biomedica Corp.'s Enterprise Value?
What is the highest Enterprise Value for Angion Biomedica Corp. (ANGN)?
What is the 3-year average Enterprise Value for Angion Biomedica Corp. (ANGN)?
What is the 5-year average Enterprise Value for Angion Biomedica Corp. (ANGN)?
How does the current Enterprise Value for Angion Biomedica Corp. (ANGN) compare to its historical average?